TRVI SG&A Expenses

Trevi Therapeutics Inc · SG&A Expenses

TRVI logo

TRVI SG&A Expenses

Latest reported$18.19M
TRVI SG&A Expenses ($1.71M → $18.19M)
High-resolution chart · PNG

TRVI sg&a expenses history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Trevi Therapeutics Inc SG&A Expenses — Annual fiscal periods (USD)
Period endingSG&A Expenses (USD)
15,850,000
12,147,000
10,240,000
10,073,000
9,492,000
10,161,000
7,306,000
4,336,000
2,142,000
1,708,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.